PeerVoice Heart & Lung Video

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

http://www.peervoice.com

Eine durchschnittliche Folge dieses Podcasts dauert 18m. Bisher sind 178 Folge(n) erschienen. Dieser Podcast erscheint wöchentlich.

Gesamtlänge aller Episoden: 2 days 15 hours 57 minutes

subscribe
share





Maintenance Therapy in COPD: Optimising Benefit With Inhalers When Ability to Inhale Is Compromised


Maintenance Therapy in COPD: Optimising Benefit With Inhalers When Ability to Inhale Is Compromised


share







   26m
 
 

Picturing a Different Future in CKD: A Call to Action


Picturing a Different Future in CKD: A Call to Action


share







   16m
 
 

Halting the Cascade of Chronic Kidney Disease: Can We Catch Patients Before They Fall?


Halting the Cascade of Chronic Kidney Disease: Can We Catch Patients Before They Fall?


share







   36m
 
 

Expanding Treatment Options in MET Exon 14-Skipping NSCLC: Clinical Insights from 2021 Virtual Congresses


Expanding Treatment Options in MET Exon 14-Skipping NSCLC: Clinical Insights from 2021 Virtual Congresses


share







 2021-10-27  5m
 
 

Shifting the Treatment Paradigm in Type 2 Diabetes and CKD: The Role of Nonsteroidal MRAs


Shifting the Treatment Paradigm in Type 2 Diabetes and CKD: The Role of Nonsteroidal MRAs


share







 2021-10-22  10m
 
 

Raising the Bar in Heart Failure Management: 2021 Congress Updates on SGLT2 Inhibitors


Raising the Bar in Heart Failure Management: 2021 Congress Updates on SGLT2 Inhibitors


share







 2021-10-20  12m
 
 

Make It a Double? Expert Insights on the Role of Dual Immunotherapy Regimens in First-Line NSCLC Treatment


Make It a Double? Expert Insights on the Role of Dual Immunotherapy Regimens in First-Line NSCLC Treatment


share







 2021-09-21  10m
 
 

Raising the Bar in Heart Failure Management: 2021 Congress Updates on SGLT2 Inhibitors


Raising the Bar in Heart Failure Management: 2021 Congress Updates on SGLT2 Inhibitors


share







 2021-08-12  12m
 
 

ASCVD: Reducing the Struggle of Keeping LDL-C at Recommended Levels


ASCVD: Reducing the Struggle of Keeping LDL-C at Recommended Levels


share







 2021-08-03  25m
 
 

Raising the Bar in Heart Failure Management: 2021 Congress Updates on SGLT2 Inhibitors


Raising the Bar in Heart Failure Management: 2021 Congress Updates on SGLT2 Inhibitors


share







 2021-07-27  10m